CANCER INVESTIGATION

在全球拥有近18000个订户，癌症研究是基础和临床肿瘤学领域最受重视和认可的期刊之一。它旨在为医生提供癌症领域当前进展状况的全面资源，以及有效决策所需的可靠信息的广泛背景。除了发表具有重要意义的原始论文外，它还发表评论、论文、争议的专门介绍、对新技术及其在具体实验室问题上的应用的考虑、公共问题的讨论、关于主要主题的小系列、新的和实验性药物和疗法，以及致编辑部的无创意信函。《华尔街日报》的一个独特之处是其部门化的编辑部分，报告了30多个学科类别，涵盖了广泛的专门领域，这些领域共同构成了肿瘤学领域。由主要的医生和研究科学家编辑，这些部分使癌症调查成为临床医生寻求理解这个领域中有时大量信息的主要资源。除了同行评审的临床研究外，该杂志还以翻译研究为特色，弥合实验室和临床之间的差距。

With nearly 18,000 subscribers worldwide, Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.